Cha University
Clinical trials sponsored by Cha University, explained in plain language.
-
Suicide gene stem cells take on brain cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment for newly diagnosed glioblastoma, a fast-growing brain cancer. After standard surgery, patients receive an injection of donor stem cells that carry a 'suicide gene' directly into the brain. The goal is to see if this approach is safe a…
Phase: PHASE1 • Sponsor: CHA University • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
4-Drug cocktail takes on tough bile duct cancer
Disease control Recruiting nowThis study tests a combination of four drugs (three chemotherapies plus an immunotherapy) in people with advanced bile duct or gallbladder cancer that has not been treated before. The goal is to see if this mix can shrink tumors and help patients live longer. About 61 adults will…
Sponsor: CHA University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Could colchicine replace aspirin after a heart attack?
Disease control Recruiting nowThis study tests whether a drug called colchicine, combined with a blood thinner, can safely replace aspirin after a heart stent procedure. About 490 participants will take colchicine and stop aspirin the day after their procedure. The goal is to see if this approach reduces hear…
Phase: PHASE4 • Sponsor: CHA University • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
AI-Powered ECG could speed up heart attack detection in crowded ERs
Diagnosis Recruiting nowThis study tests whether an AI-assisted ECG reading is as safe and effective as the usual method for quickly deciding if a patient with chest pain is having a heart attack. About 4,670 adults with chest pain and suspected heart attack will be randomly assigned to either AI-guided…
Phase: NA • Sponsor: CHA University • Aim: Diagnosis
Last updated May 26, 2026 06:48 UTC
-
Blood test may replace biopsies for bile duct cancer patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for tumor DNA (ctDNA) can find genetic changes in advanced bile duct cancer as well as a standard tissue biopsy. Researchers will enroll 200 adults with advanced biliary tract cancer across multiple hospitals in Korea. The goa…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated May 26, 2026 06:48 UTC
-
Scientists hunt for genetic signs to personalize bile duct cancer therapy
Knowledge-focused Recruiting nowThis study is for people with advanced bile duct cancer who are already scheduled to receive a combination of two drugs, lenvatinib and pembrolizumab. Researchers will collect blood and tumor samples to look for genetic markers that might predict who benefits most from this treat…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated May 26, 2026 06:47 UTC
-
Blood test could replace needle biopsies for bile duct cancer patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test that looks for tumor DNA (ctDNA) can find important genetic changes in people with advanced bile duct cancer. Normally, doctors need a tissue sample from the tumor, which can be hard to get. The study will enroll 100 adults in Korea and …
Sponsor: CHA University • Aim: Knowledge-focused
Last updated May 26, 2026 06:41 UTC